Biozen | Cuffless BP Monitor & Digital Health Solutions

Biozen | Cuffless BP Monitor & Digital Health Solutions

2

Company Profile

Biozen, LLC is a US-based digital health company and    medical device manufacturer, headquartered in    Oklahoma City, Oklahoma, USA, with research and development in    Atlanta, Georgia. Founded in    2010, the company operates as an independent privately-held entity employing approximately    26 people,    serving clinicians, healthcare partners and adult patients across the United States.

Core Products & Technologies

Cuffless Blood Pressure Monitoring

Biozen BP1000: FDA-cleared ultra-compact fingertip blood pressure monitor delivering calibration-free spot measurements for adults ages 22-59
   • Companion Mobile App: Visual-guided interface that logs readings and maintains comprehensive measurement history

Platform Technology

Proprietary Pressure Sensing: Direct arterial occlusion detection through fingertip application
   • Photoplethysmography (PPG): Optical blood volume change tracking paired with pressure signals
   • Physiologically Informed Algorithms: Oscillometric-method computation without per-user calibration against arm cuffs

Market Position & Certifications

Biozen holds a pioneering position in the cuffless blood pressure monitoring market,    competing with Biobeat and    Aktiia. Key strengths include:

15+ years of biosensor and digital health research and development heritage
   • Direct Measurement Principle: Absolute blood pressure measurement from the fingertip without estimation or correlation models
   • Regulatory compliance: FDA 510(k) cleared (May 2026), validated against ISO 81060-2:2018 for equivalence to cuff-based references
   • Intellectual property: Platform protected by more than 68 granted US and international patents

Corporate Timeline

2010 — Founded as a digital health innovator focused on advanced biosensors
   2023 — Completed later-stage venture capital financing to scale commercial operations
   2026 — Named finalist in ACC Innovation Pitch Challenge; presented prospective clinical validation data at ACC
   2026 — Received FDA 510(k) clearance for BP1000 on May 11; opened early access program for clinicians and partners

Target Markets & Applications

Home Blood Pressure Monitoring: BP1000 for adults seeking convenient, cuffless spot measurements in home environments
   • Primary Care & Cardiology Clinics: Calibration-free clinical-grade readings to improve patient compliance and monitoring frequency
   • Future Device Integration: BP Sensor platform licensing for smartphones, wearables and connected health ecosystems

Contact Information

Global Headquarters

Address: 7023 N. Classen Blvd., Oklahoma City, Oklahoma 73116, USA
   Phone: +1 405-413-5201
   Email: aw@biozen.com
   Website: www.biozen.com

Research & Development Center

Address: Atlanta, Georgia, USA

文章下方广告位

网友评论

访客信息

你已经3分钟没有访问该网站

这些可能是你需要的内容: